SAN FRANCISCO, May 13, 2020 /PRNewswire/ — The global optical preclinical imaging market size is expected to reach USD 543.0 million by the end of 2027, expanding at a CAGR of 3.3%, according to a new report by Grand View Research, Inc. Increasing number of preclinical studies aimed to study and develop various effective therapeutics for different diseases is a major factor boosting the adoption of optical preclinical imaging systems.


Key suggestions from the report:

North America accounted for the largest share in 2019 owing to well-established research infrastructure, adoption of guidelines for preclinical research, product approvals, and higher number of drug development projects

Based on product type, in the device segment, bioluminescence captured the largest optical preclinical imaging market share in 2019 owing to high sensitivity and broad